Trial Profile
A Multicentre Study Assessing Safety, Tolerability And Efficacy Of Dimethyl Fumarate In A Real World Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 26 Dec 2016 New trial record